Brief: Qyuns Therapeutics Co Says Obtained IND Clearance For QX013N
09/05/2024 14:40
May 9 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK :
* QYUNS OBTAINED IND CLEARANCE FOR QX013N FOR TREATMENT OF
CHRONIC
SPONTANEOUS URTICARIA IN CHINA
* QX013N RECEIVED INVESTIGATIONAL NEW DRUG CLEARANCE FROM
CENTER
FOR DRUG EVALUATION OF NMPA OF CHINA
Further company coverage: 2509.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qyuns Therapeutics
See all newsBrief: QYUNS Therapeutics Posts HY Adjusted Profit Of RMB202.5 MLN
Brief: Qyuns Therapeutics Says Qx027n Obtains Two Clinical Trial Approvals For Copd, Chronic Rhinosinusitis
Brief: Qyuns Therapeutics Says Saifu Juli To Buy 34% Of Cellularforce For RMB86.02 Million
Brief: Qyuns Therapeutics Repurchases 3.43 Million Shares As Treasury Shares From Nov 6, 2025 To June 9
Brief: Qyuns Therapeutics Co Receives Milestone Payment From Roche